Cardiology Department, Centre Hospitalier Sud-Francilien (CHSF), Corbeil-Essonnes, France.
Clinical Physiology Department, Hôpital Lariboisière, Paris, France.
Sci Rep. 2022 Aug 30;12(1):14798. doi: 10.1038/s41598-022-18410-6.
Erythrocyte aggregation (EA) is a physiological process by which erythrocytes reversibly stick together within the blood vessels. EA plays a major role in blood viscosity in vivo, thereby impacting blood flow to organs. EA is no doubt greatly important in both physiological and pathophysiological conditions, but the studies its importance calls for are complicated by the lack of a reliable and easy way to measure it. We have developed a new point-of-care technique which can very specifically measure EA initial kinetics (EAK) in 20 s directly on blood samples routinely collected in tubes commonly used in clinical settings. We present the results of the validation studies of this EAK test: A mono-exponential curve explains 99% of EAK variance. EAK is normally distributed in healthy individuals, with an interindividual 15% coefficient of variation and is stable for least one hour after blood collection. Intraindividual coefficient of variation is 2.6%. EA can now be easily measured in any clinical setting.
红细胞聚集(EA)是一种生理过程,其中红细胞在血管内可逆地粘在一起。EA 在体内血液粘度中起主要作用,从而影响器官的血流。EA 在生理和病理生理条件下无疑都非常重要,但由于缺乏可靠和简便的测量方法,对其重要性的研究变得复杂。我们开发了一种新的即时护理技术,可以在 20 秒内直接在临床上常用的常规采血管中采集的血液样本上非常特异性地测量 EA 初始动力学(EAK)。我们呈现了该 EAK 测试的验证研究结果:单指数曲线解释了 99%的 EAK 方差。EAK 在健康个体中呈正态分布,个体间变异系数为 15%,在采血后至少 1 小时内稳定。个体内变异系数为 2.6%。EA 现在可以在任何临床环境中轻松测量。